| Volume: | 3,994,747 |
|---|---|
| Day's Low: | $51.07 |
| 52-wk Low: | $41.27 |
| Previous Close: | $51.62 |
| Dividend: | $0.40 |
| Market Cap: | 79,660,900 |
| Avg Volume: | 8,070,700 |
|---|---|
| Day's High: | $51.59 |
| 52-wk High: | $57.39 |
| Open Price: | $51.45 |
| Yield: | 3.10% |
| P/E (Forward): | 13.89 |
| 3:17 PM | 11/6/2009 | UPDATE: Abbott Labs: US Justice Department Probing Depakote |
| 11:33 AM | 11/6/2009 | Abbott Labs: US Justice Department Probing Depakote Marketing |
| 10:33 AM | 11/3/2009 | Merck/Schering Cholesterol Drugs At Another Crossroads |
| 12:33 PM | 11/2/2009 | UPDATE: Boston Sci's Promus Element Stents Approved In Europe |
| 10:01 AM | 11/2/2009 | Boston Scientific's Promus Element Stents Approved In Europe |
| 3:49 PM | 10/26/2009 | EU Committee To Size Up Abbott, Solvay Cholesterol Drugs |
| 3:08 PM | 10/22/2009 | US Drug Makers 3Q Helped By Cost Cuts, Major Product Sales |
| 11/3/2009 | Johnson & Johnson to cut up to 8,200 jobs |
| 11/3/2009 | J&J To Cut 7% of Workforce |
| 11/3/2009 | Money Managers Are Still Bullish |
| 11/2/2009 | Treading Carefully |
| 11/2/2009 | Turnaround Letter not for faint of heart |
| 11/2/2009 | Trade like a fund manager |
| 11/1/2009 | Employers Brace for Swine Flu |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.92 | 0.79 | 16.46 |
| EPS, GAAP | 0.95 | 0.69 | 37.68 |
| Consensus Estimate | 0.90 | 0.77 | 16.88 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 3.61 | 3.32 | 8.73 |
| EPS, GAAP | 3.42 | 2.91 | 17.53 |
| Consensus Estimate | 3.55 | NA | NA |
| ABT | Industry Average | |
| P/E (TTM) | 15.07 | 18.40 |
| P/E (Forward) | 13.89 | -4.30 |
| PEG Ratio | 1.23 | -0.28 |
| Price/Sales | 2.69 | 2.94 |
| Beta | 0.18 | 0.23 |